Kahve tüketimi ve bazı hastalıklarla ilişkisi: son yıllarda yapılan insan temelli araştırmaların irdelenmesi

Yıl 2017, Cilt: 8 Sayı: 2, 33 - 39, 14.04.2017

Saniye Sözlü , Birsen Yılmaz , Nilüfer Acar Tek

https://doi.org/10.22312/sdusbed.273937

Cited By: 2

Öz

Kahve
dünyada en çok tüketilen içecekler arasında yer almaktadır. Kahve sağlık
üzerine etkilerini özellikle kahve bileşikleri olan kafein, diterpen alkoller ve
klorojenik asit aracılığı ile gerçekleştirmektedir. Geçmişte yapılan
epidemiyolojik çalışmalarda kahve ve kafein tüketiminin potansiyel olarak
sağlığı olumsuz yönde etkilediği düşülse de, son zamanlarda yapılan araştırma
sonuçları kahve tüketiminin bazı kronik hastalıkların riskini azaltmada etkin
olabileceği görüşü bulunmaktadır. Başlıca etki gösterdiği hastalıklar arasında
kardiyovasküler hastalıklar, hipertansiyon ve aritmi, kanser, osteoporoz ve
diyabet bulunmaktadır. Bu derleme, kahve tüketiminin insan sağlığı üzerine
yararları ve risklerini araştıran çalışmaları incelemek ve yorumlamak amacı ile
yazılmıştır.

Anahtar Kelimeler

Kahve, Kafein, kronik hastalıklar

Kaynakça

• 1. Esquivel P, Jiménez VM. Functional properties of coffee and coffee by-products. Food Res Int 2012; 46(2): 488-95.
• 2. Willett WC, Stampfer MJ, Manson JE, Colditz GA, Rosner BA, Speizer FE, et al. Coffee consumption and coronary heart disease in women. A ten-year follow-up. Jama 1996; 275(6): 458-62.
• 3. Ascherio A, Zhang SM, Hernan MA, Kawachi I, Colditz GA, Speizer FE, et al. Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann Neurol 2001; 50(1): 56-63.
• 4. La Vecchia C. Coffee, liver enzymes, cirrhosis and liver cancer. J Hepatol 2005; 42(4): 444-6. doi: 10.1016/j.jhep.2005.01.004
• 5. Bhatti SK, O'Keefe JH, Lavie CJ. Coffee and tea: perks for health and longevity? Curr Opin Clin Nutr Metab Care 2013; 16(6) :688-97. doi: 10.1097/MCO.0b013e328365b9a0
• 6. Cano-Marquina A, Tarin JJ, Cano A. The impact of coffee on health. Maturitas 2013; 75(1): 7-21. doi: 10.1016/j.maturitas.2013.02.002
• 7. Crews HM, Olivier L, Wilson LA. Urinary biomarkers for assessing dietary exposure to caffeine. Food Addit Contam 2001; 18(12): 1075-87. doi: 10.1080/02652030110056630
• 8. McCusker RR, Goldberger BA, Cone EJ. Caffeine content of specialty coffees. J Anal Toxicol 2003; 27(7): 520-2.
• 9. Higdon JV, Frei B. Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr 2006; 46(2): 101-23. doi: 10.1080/10408390500400009
• 10. Naidoo N, Chen C, Rebello SA, Speer K, Tai ES, Lee J, et al. Cholesterol-raising diterpenes in types of coffee commonly consumed in Singapore, Indonesia and India and associations with blood lipids: a survey and cross sectional study. Nutr J 2011; 10:48. doi: 10.1186/1475-2891-10-48
• 11. Jee SH, He J, Appel LJ, Whelton PK, Suh I, Klag MJ. Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol 2001; 153(4): 353-62.
• 12. Stalmach A, Mullen W, Nagai C, Crozier A. On-line HPLC analysis of the antioxidant activity of phenolic compounds in brewed, paper-filtered coffee. Brazilian Journal of Plant Physiology 2006; 18(1): 253-62.
• 13. Cornelis MC, El-Sohemy A. Coffee, caffeine, and coronary heart disease. Curr Opin Clin Nutr Metab Care 2007; 10(6): 745-51. doi: 10.1097/MCO.0b013e3282f05d81
• 14. Bak AA, Grobbee DE. The effect on serum cholesterol levels of coffee brewed by filtering or boiling. N Engl J Med 1989; 321(21): 1432-7. doi: 10.1056/nejm198911233212103
• 15. Splaver A, Lamas GA, Hennekens CH. Homocysteine and cardiovascular disease: biological mechanisms, observational epidemiology, and the need for randomized trials. Am Heart J 2004; 148(1): 34-40. doi: 10.1016/j.ahj.2004.02.004
• 16. Husemoen LL, Thomsen TF, Fenger M, Jorgensen T. Effect of lifestyle factors on plasma total homocysteine concentrations in relation to MTHFR(C677T) genotype. Inter99 (7). Eur J Clin Nutr 2004; 58(8): 1142-50. doi: 10.1038/sj.ejcn.1601942
• 17. Mennen LI, de Courcy GP, Guilland JC, Ducros V, Bertrais S, Nicolas JP, et al. Homocysteine, cardiovascular disease risk factors, and habitual diet in the French Supplementation with Antioxidant Vitamins and Minerals Study. Am J Clin Nutr 2002; 76(6): 1279-89.
• 18. de Bree A, Verschuren WM, Blom HJ, Kromhout D. Lifestyle factors and plasma homocysteine concentrations in a general population sample. Am J Epidemiol 2001; 154(2): 150-4.
• 19. Stolzenberg-Solomon RZ, Miller ER 3rd, Maguire MG, Selhub J, Appel LJ. Association of dietary protein intake and coffee consumption with serum homocysteine concentrations in an older population. Am J Clin Nutr 1999; 69(3): 467-75.
• 20. Urgert R, van Vliet T, Zock PL, Katan MB. Heavy coffee consumption and plasma homocysteine: a randomized controlled trial in healthy volunteers. Am J Clin Nutr 2000; 72(5): 1107-10.
• 21. Kawachi I, Colditz GA, Stone CB. Does coffee drinking increase the risk of coronary heart disease? Results from a meta-analysis. Br Heart J 1994; 72(3): 269-75.
• 22. Greenland S. A meta-analysis of coffee, myocardial infarction, and coronary death. Epidemiology (Cambridge, Mass.) 1993; 4(4): 366-74.
• 23. Myers MG, Basinski A. Coffee and coronary heart disease. Arch Intern Med 1992; 152(9): 1767-72.
• 24. Woodward M, Tunstall-Pedoe H. Coffee and tea consumption in the Scottish Heart Health Study follow up: conflicting relations with coronary risk factors, coronary disease, and all cause mortality. J Epidemiol Community Health 1999; 53(8): 481-7.
• 25. Kleemola P, Jousilahti P, Pietinen P, Vartiainen E, Tuomilehto J. Coffee consumption and the risk of coronary heart disease and death. Arch Intern Med 2000; 160(22): 3393-400.
• 26. Stensvold I, Tverdal A, Jacobsen BK. Cohort study of coffee intake and death from coronary heart disease over 12 years. BMJ (Clinical research ed.) 1996; 312(7030): 544-5.
• 27. Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R. Association of coffee drinking with total and cause-specific mortality. N Engl J Med 2012; 366(20): 1891-904. doi: 10.1056/NEJMoa1112010
• 28. Siasos G, Oikonomou E, Chrysohoou C, Tousoulis D, Panagiotakos D, Zaromitidou M, et al. Consumption of a boiled Greek type of coffee is associated with improved endothelial function: the Ikaria study. Vasc Med (London, England) 2013; 18(2): 55-62. doi: 10.1177/1358863x13480258
• 29. Lang T, Bureau JF, Degoulet P, Salah H, Benattar C. Blood pressure, coffee, tea and tobacco consumption: an epidemiological study in Algiers. Eur Heart J 1983; 4(9): 602-7.
• 30. Burke V, Beilin LJ, German R, Grosskopf S, Ritchie J, Puddey IB, et al. Association of lifestyle and personality characteristics with blood pressure and hypertension: a cross-sectional study in the elderly. J Clin Epidemiol 1992; 45(10): 1061-70.
• 31. Periti M, Salvaggio A, Quaglia G, Di Marzio L. Coffee consumption and blood pressure: an Italian study. Clin Sci (London, England : 1979) 1987; 72(4): 443-7.
• 32. Stensvold I, Tverdal A, Foss OP. The effect of coffee on blood lipids and blood pressure. Results from a Norwegian cross-sectional study, men and women, 40-42 years. J Clin Epidemiol 1989; 42(9): 877-84.
• 33. Salvaggio A, Periti M, Miano L, Zambelli C. Association between habitual coffee consumption and blood pressure levels. J Hypertens 1990; 8(6): 585-90.
• 34. Lancaster T, Muir J, Silagy C. The effects of coffee on serum lipids and blood pressure in a UK population. J R Soc Med 1994; 87(9): 506-7.
• 35. Mesas AE, Leon-Munoz LM, Rodriguez-Artalejo F, Lopez-Garcia E. The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis. Am J Clin Nutr 2011; 94(4): 1113-26. doi: 10.3945/ajcn.111.016667
• 36. Renda G, Zimarino M, Antonucci I, Tatasciore A, Ruggieri B, Bucciarelli T, et al. Genetic determinants of blood pressure responses to caffeine drinking. Am J Clin Nutr 2012; 95(1): 241-8. doi: 10.3945/ajcn.111.018267
• 37. Robertson D, Wade D, Workman R, Woosley RL, Oates JA. Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest 1981; 67(4): 1111-7.
• 38. Steffen M, Kuhle C, Hensrud D, Erwin PJ, Murad MH. The effect of coffee consumption on blood pressure and the development of hypertension: a systematic review and meta-analysis. J Hypertens 2012; 30(12): 2245-54. doi: 10.1097/HJH.0b013e3283588d73
• 39. Klag MJ, Wang NY, Meoni LA, Brancati FL, Cooper LA, Liang KY, et al. Coffee intake and risk of hypertension: the Johns Hopkins precursors study. Arch Intern Med 2002; 162(6): 657-62.
• 40. Cheng M, Hu Z, Lu X, Huang J, Gu D. Caffeine intake and atrial fibrillation incidence: dose response meta-analysis of prospective cohort studies. Can J Cardiol 2014; 30(4): 448-54. doi: 10.1016/j.cjca.2013.12.026
• 41. Klatsky AL, Hasan AS, Armstrong MA, Udaltsova N, Morton C. Coffee, caffeine, and risk of hospitalization for arrhythmias. Perm J 2011; 15(3): 19-25.
• 42. Glatter KA, Myers R, Chiamvimonvat N. Recommendations regarding dietary intake and caffeine and alcohol consumption in patients with cardiac arrhythmias: what do you tell your patients to do or not to do? Curr Treat Options Cardiovasc Med 2012; 14(5): 529-35. doi: 10.1007/s11936-012-0193-6
• 43. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood pressure. Hypertension 2009; 18(6): 308-47. doi: 10.3109/08037050903450468
• 44. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42(6): 1206-52. doi: 10.1161/01.HYP.0000107251.49515.c2
• 45. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). Jama 2014; 311(5): 507-20. doi: 10.1001/jama.2013.284427
• 46. Noordzij M, Uiterwaal CS, Arends LR, Kok FJ, Grobbee DE, Geleijnse JM. Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. J Hypertens 2005; 23(5): 921-8.
• 47. Bohn SK, Blomhoff R, Paur I. Coffee and cancer risk, epidemiological evidence, and molecular mechanisms. Mol Nutr Food Res 2014; 58(5): 915-30. doi: 10.1002/mnfr.201300526
• 48. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003; 3(10): 768-80. doi: 10.1038/nrc1189
• 49. Mursu J, Voutilainen S, Nurmi T, Alfthan G, Virtanen JK, Rissanen TH, et al. The effects of coffee consumption on lipid peroxidation and plasma total homocysteine concentrations: a clinical trial. Free Radic Biol Med 2005; 38(4): 527-34. doi: 10.1016/j.freeradbiomed.2004.11.025
• 50. Yamashita K, Yatsuya H, Muramatsu T, Toyoshima H, Murohara T, Tamakoshi K. Association of coffee consumption with serum adiponectin, leptin, inflammation and metabolic markers in Japanese workers: a cross-sectional study. Nutr Diabetes 2012; 2:e33. doi: 10.1038/nutd.2012.6
• 51. Crozier TW, Stalmach A, Lean ME, Crozier A. Espresso coffees, caffeine and chlorogenic acid intake: potential health implications. Food Funct 2012; 3(1): 30-3. doi: 10.1039/c1fo10240k
• 52. Riksen NP, Smits P, Rongen GA. The cardiovascular effects of methylxanthines. Handb Exp Pharmacol 2011(200): 413-37. doi: 10.1007/978-3-642-13443-2_16
• 53. Jiang W, Wu Y, Jiang X. Coffee and caffeine intake and breast cancer risk: an updated dose-response meta-analysis of 37 published studies. Gynecol Oncol 2013; 129(3): 620-9. doi: 10.1016/j.ygyno.2013.03.014
• 54. Simonsson M, Soderlind V, Henningson M, Hjertberg M, Rose C, Ingvar C, et al. Coffee prevents early events in tamoxifen-treated breast cancer patients and modulates hormone receptor status. Cancer Causes Control 2013; 24(5): 929-40. doi: 10.1007/s10552-013-0169-1
• 55. Lai GY, Weinstein SJ, Albanes D, Taylor PR, Mcglynn KA, Virtamo J, et al. The association of coffee intake with liver cancer incidence and chronic liver disease mortality in male smokers. Br J Cancer 2013; 109(5): 1344-51. doi: 10.1038/bjc.2013.405
• 56. Tian C, Wang W, Hong Z, Zhang X. Coffee consumption and risk of colorectal cancer: a dose-response analysis of observational studies. Cancer Causes Control 2013; 24(6): 1265-8. doi: 10.1007/s10552-013-0200-6
• 57. Lemann J, Jr., Litzow JR, Lennon EJ. The effects of chronic acid loads in normal man: further evidence for the participation of bone mineral in the defense against chronic metabolic acidosis. J Clin Invest 1966; 45(10): 1608-14. doi: 10.1172/jci105467
• 58. Rapuri PB, Gallagher JC, Kinyamu HK, Ryschon KL. Caffeine intake increases the rate of bone loss in elderly women and interacts with vitamin D receptor genotypes. Am J Clin Nutr 2001; 74(5): 694-700.
• 59. Korpelainen R, Korpelainen J, Heikkinen J, Vaananen K, Keinanen-Kiukaanniemi S. Lifestyle factors are associated with osteoporosis in lean women but not in normal and overweight women: a population-based cohort study of 1222 women. Osteoporos Int 2003; 14(1): 34-43. doi: 10.1007/s00198-002-1319-6
• 60. Yoshimura N, Suzuki T, Hosoi T, Orimo H. Epidemiology of hip fracture in Japan: incidence and risk factors. J Bone Miner Metab 2005; 23 Suppl: 78-80.
• 61. Franceschi S, Schinella D, Bidoli E, Dal Maso L, La Vecchia C, Parazzini F, et al. The influence of body size, smoking, and diet on bone density in pre- and postmenopausal women. Epidemiology (Cambridge, Mass.) 1996; 7(4): 411-4.
• 62. Lloyd T, Rollings N, Eggli DF, Kieselhorst K, Chinchilli VM. Dietary caffeine intake and bone status of postmenopausal women. Am J Clin Nutr 1997; 65(6): 1826-30.
• 63. Takami H, Nakamoto M, Uemura H, Katsuura S, Yamaguchi M, Hiyoshi M, et al. Inverse correlation between coffee consumption and prevalence of metabolic syndrome: baseline survey of the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study in Tokushima, Japan. J Epidemiol / Japan Epidemiological Association 2013; 23(1): 12-20.
• 64. O'Keefe JH, Bhatti SK, Patil HR, DiNicolantonio JJ, Lucan SC, Lavie CJ. Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-cause mortality. J Am Coll Cardiol 2013; 62(12): 1043-51. doi: 10.1016/j.jacc.2013.06.035
• 65. Bhupathiraju SN, Pan A, Malik VS, Manson JE, Willett WC, van Dam RM, et al. Caffeinated and caffeine-free beverages and risk of type 2 diabetes. Am J Clin Nutr 2013; 97(1): 155-66. doi: 10.3945/ajcn.112.048603
• 66. Huxley R, Lee CM, Barzi F, Timmermeister L, Czernichow S, Perkovic V, et al. Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med 2009; 169(22): 2053-63. doi: 10.1001/archinternmed.2009.439
• 67. Lucas M, Mirzaei F, Pan A, Okereke OI, Willett WC, O'Reilly EJ, et al. Coffee, caffeine, and risk of depression among women. Arch Intern Med 2011; 171(17): 1571-8. doi: 10.1001/archinternmed.2011.393
• 68. Acheson KJ, Zahorska-Markiewicz B, Pittet P, Anantharaman K, Jequier E. Caffeine and coffee: their influence on metabolic rate and substrate utilization in normal weight and obese individuals. Am J Clin Nutr 1980; 33(5): 989-97.
• 69. Massey LK, Whiting SJ. Caffeine, urinary calcium, calcium metabolism and bone. J Nutr 1993; 123(9): 1611-4.